Literature DB >> 17513739

Distinct subsets of FoxP3+ regulatory T cells participate in the control of immune responses.

Geoffrey L Stephens1, John Andersson, Ethan M Shevach.   

Abstract

Expression of the transcription factor FoxP3 is the hallmark of regulatory T cells that play a crucial role in dampening immune responses. A comparison of the development and phenotype of FoxP3(+) T cells in relation to the expression of conventional MHC molecules facilitated the identification of several distinct lineages of naive and effector/memory populations of Foxp3(+) T cells. One subpopulation of effector/memory Foxp3(+) T cells develops in the thymic medulla, whereas the second is thymic independent. Both lineages display a distinct activated phenotype, undergo extensive steady-state proliferation, home to sites of acute inflammation, and are unique in their capacity to mediate Ag-nonspecific suppression of T cell activation directly ex vivo. Effector FoxP3(+) T cells may act as a sentinel of tolerance, providing a first line of defense against potentially harmful responses by rapidly suppressing immunity to peripheral self-Ags.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17513739     DOI: 10.4049/jimmunol.178.11.6901

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  46 in total

1.  Genomic definition of multiple ex vivo regulatory T cell subphenotypes.

Authors:  Markus Feuerer; Jonathan A Hill; Karsten Kretschmer; Harald von Boehmer; Diane Mathis; Christophe Benoist
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-15       Impact factor: 11.205

Review 2.  Breaking through a plateau in renal cell carcinoma therapeutics: development and incorporation of biomarkers.

Authors:  Sumanta Kumar Pal; Marcin Kortylewski; Hua Yu; Robert A Figlin
Journal:  Mol Cancer Ther       Date:  2010-11-15       Impact factor: 6.261

Review 3.  The T-cell receptor repertoire of regulatory T cells.

Authors:  Rafal Pacholczyk; Joanna Kern
Journal:  Immunology       Date:  2008-12       Impact factor: 7.397

Review 4.  Foxp3+ regulatory T cells: differentiation, specification, subphenotypes.

Authors:  Markus Feuerer; Jonathan A Hill; Diane Mathis; Christophe Benoist
Journal:  Nat Immunol       Date:  2009-07       Impact factor: 25.606

5.  Diversification and senescence of Foxp3+ regulatory T cells during experimental autoimmune encephalomyelitis.

Authors:  Sharyn Tauro; Phuong Nguyen; Bofeng Li; Terrence L Geiger
Journal:  Eur J Immunol       Date:  2013-04-09       Impact factor: 5.532

Review 6.  Heterogeneity and Stability in Foxp3+ Regulatory T Cells.

Authors:  Booki Min
Journal:  J Interferon Cytokine Res       Date:  2017-07-11       Impact factor: 2.607

7.  Targeting ganglioside epitope 3G11 on the surface of CD4+ T cells suppresses EAE by altering the Treg/Th17 cell balance.

Authors:  Zhao Zhao; Bogoljub Ciric; Shuo Yu; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  Int Immunol       Date:  2010-08-02       Impact factor: 4.823

Review 8.  Treg cells, life history, and diversity.

Authors:  Christophe Benoist; Diane Mathis
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-09-01       Impact factor: 10.005

Review 9.  Heterogeneity and plasticity of T helper cells.

Authors:  Jinfang Zhu; William E Paul
Journal:  Cell Res       Date:  2009-12-15       Impact factor: 25.617

10.  Anti-CD3 therapy permits regulatory T cells to surmount T cell receptor-specified peripheral niche constraints.

Authors:  Junko Nishio; Markus Feuerer; Jamie Wong; Diane Mathis; Christophe Benoist
Journal:  J Exp Med       Date:  2010-08-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.